Drinalizumab: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Drinalizumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
(No difference)
|
Latest revision as of 20:20, 27 September 2011
Drinalizumab is a humanized monoclonal antibody which it is used as an immunosuppresive drug and it is used to treat Type 1 diabetes.
 | This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |